Methods for improving resveratrol yield and cell wall digestibility in plants using dual-enzyme combinations
By reconstructing the phenylalanine biosynthesis pathway in the plant chassis and utilizing the combined expression of AroG* and PcRS, the problems of resource constraints and microbial metabolic imbalance in resveratrol production were solved, achieving efficient resveratrol synthesis and high-value utilization of biomass, and promoting sustainable energy development.
Patent Information
- Application Number
- CN202510614735.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-14
- Publication Date
- 2026-11-17
AI Technical Summary
The traditional production mode of resveratrol in the present technology is limited by the low abundance of raw materials and the unsustainability of ecological resources. The microbial chassis is subject to the risk of metabolic imbalance and pathogen contamination. Moreover, the cost of synthetic carbon source is expensive, making it difficult to achieve efficient and stable commercial utilization.
By employing a plant chassis system, the phenylalanine biosynthesis pathway was reconstructed. The combined expression of 3-deoxy-D-arabino-heptanurate synthase (AroG*) and resveratrol synthase (PcRS) without negative feedback inhibition was utilized to improve the efficiency of resveratrol synthesis and to modify the plant cell wall structure to enhance biomass digestibility.
In model plants, resveratrol yield was increased by 2.1 times and cell wall saccharification efficiency was improved by 83%, achieving efficient synthesis of resveratrol and high-value utilization of biomass, reducing production costs and promoting sustainable energy development.
Smart Images

Figure BDA0005400667080000121 
Figure BDA0005400667080000131 
Figure BDA0005400667080000132
Abstract
Description
Technical Field
[0001] This invention belongs to the field of agricultural biotechnology and relates to a method for improving the yield of resveratrol in plants and / or improving the digestibility of plant cell walls through a combination of two enzymes. Background Technology
[0002] Resveratrol, a natural secondary metabolite with significant medicinal value, faces major challenges in its traditional production methods: natural plant extraction is limited by low raw material abundance and unsustainable ecological resources, making it difficult to meet market demand (Wang et al., 2020). Utilizing synthetic biology methods to produce resveratrol is a feasible alternative strategy. Currently, some progress has been made in the synthesis of resveratrol in microbial chassis. For example, by fusing Pc4CL1-VvSTS with *Yarrowia lipolytica* and simultaneously increasing the supply of malonyl-CoA precursors, the resveratrol yield reached 22.5 g / L after process optimization, with a yield as high as 0.16 g / L / h (Liu et al., 2022); by selectively knocking out genes encoding glycosidases to inhibit the degradation of resveratrol glycosides, a production capacity of 6.88 g / L was achieved in *Yarrowia lipolytica* using glucose as a carbon source (Shang et al., 2023). However, microbial chassis have some limitations: 1) synthesizing large amounts of heterologous products can lead to metabolic imbalances in the microorganisms, resulting in decreased yield or unstable quality; 2) their products pose a potential risk of contamination by human pathogens; and 3) the high cost of synthetic carbon sources limits their commercial application. Against this backdrop, plant-based synthetic biology strategies are demonstrating unique advantages.
[0003] Plant chassis systems, with their natural adaptability, offer a more sustainable solution for resveratrol synthesis. Compared to microbial systems, plant cells possess three core advantages: 1) Their compartmentalized cellular structure supports the targeted storage and transformation of target products, reducing harm to engineered cells and maintaining the stability of the cell factory; 2) Their endogenous metabolic networks and secondary metabolite synthesis pathways are naturally compatible. For example, the plant resveratrol synthesis pathway and the lignin precursor synthesis pathway share multiple synthases, allowing for product accumulation through relatively simple genetic engineering. For instance, up to 0.12 mg of resveratrol can accumulate in the hairy roots of the transgenic MbSTS7 mulberry tree. / g (Wu Shukuan 2021); 3) Plant endogenous precursor enhancement strategies can be used to overcome metabolic flux limitations and achieve efficient accumulation of metabolites. For example, by overexpressing phenylalanine ammonia-lyase (PAL) to enhance the metabolic flux of synthetic precursors, and by using gene editing to knock out the branched synthetic pathway of ginsenosides, the yield of ginsenoside Rg3 in ginseng plant roots reached as high as 83.6 mg / L, while the Rg3 content reported in engineered yeast is only 2.7 mg / g (Yao et al. 2022; Wang et al. 2015). Therefore, through reasonable synthetic biology design and metabolic engineering modification, plant chassis are also expected to become a highly efficient synthetic platform for novel resveratrols.
[0004] Lignin in higher plants provides the rigid structure of the plant and plays an indispensable role in the transport of water and nutrients and defense against pathogens. The synthesis pathway of plant lignin monomers is downstream of the shikimic acid metabolic pathway. A 3-deoxy-D-arabino-heptanolate synthase (DAHPS / AroG) without negative feedback inhibition can alter the shikimic acid metabolic flux, especially enhancing the flux of phenylalanine via the carbon cycle towards lignin monomer synthesis (Tzin et al., 2012). However, the difficulty in depolymerizing lignin also hinders the bioconversion and high-value utilization of lignocellulose biomass. Reducing the lignin content in plant biomass can improve bioconversion efficiency, but lignin modification often leads to reduced biomass yield, resulting in the so-called "lignin modification-induced plant dwarfing" phenomenon (Xu Li et al., 2010; De Meester et al., 2020). Furthermore, studies have found that genetic engineering to modify lignin structure can also improve cell wall saccharification efficiency, increasing the bioconversion rate and high-value utilization rate of lignocellulose biomass. For example, overexpression of the HCHL gene can shorten the side chain and integrate lignin monomers into lignin polymers, thereby reducing the degree of polymerization of synthesized lignin and increasing the digestibility of biomass (Zhang Yang et al. 2021). Overexpression of the FMT gene of Angelica sinensis in poplar can integrate the lignin monomer ferulic ester into the lignin polymer of hybrid poplar, forming the so-called "Zip-lignin", which in turn increases the cell wall digestibility under alkaline conditions (Wilkerson et al. 2014).
[0005] Recent studies have discovered that certain hydroxystilbenes in specific plants, such as resveratrol, lecithin, isotanyl emodin, and their corresponding glycosylated products, polygalactoside and isotanyl emodin, can also participate in lignin polymerization and are referred to as "non-traditional lignin monomers" (DEL RíO JC et al. 2020). These non-traditional lignins possess more diverse active sites and functional groups, thus showing great potential for utilization. However, they accumulate only in specific tissues of specific species, limiting their application value. Summary of the Invention
[0006] In our research on heterologous synthesis of resveratrol from plants or increasing resveratrol yield, based on the analysis of the resveratrol biosynthetic pathway, our research group focused on the effects of some enzymes in the phenylalanine biosynthesis pathway on resveratrol production. We inferred that increased enzyme activities of 3-deoxy-D-arabino-heptulosonate synthase (DAHPS) and resveratrol synthase promote resveratrol biosynthesis. Furthermore, in studies on the biosynthetic pathways of plant lignin monomers, it was found that AroG (amino acid sequence shown in SEQ ID NO:8), one of the three DAHPS isoform enzymes from *E. coli*, significantly affects the flux of phenylalanine synthesis and lignin monomer synthesis. A mutant of AroG (amino acid sequence shown in SEQ ID NO:1, abbreviated as AroG*) is not subject to feedback inhibition by aromatic amino acids (tyrosine, phenylalanine, and tryptophan) produced by the shikimic acid metabolic pathway. We devised a strategy to reconstruct the hydroxystilbene biosynthetic pathway in lignified plant tissues, combining the biosynthesis technology of resveratrol (a "non-traditional lignin monomer") with lignin depolymerization technology. The aim is to heterologously express and accumulate resveratrol in plant tissues that previously could not accumulate it, increase the accumulation level of resveratrol in plant tissues that could already accumulate it, and alter the composition ratio of lignin and polysaccharide components in the cell wall to improve the digestibility of plant cell walls, thereby facilitating the bioconversion and high-value utilization of lignocellulose biomass.
[0007] To verify the above technical concept, we decided to conduct a combined AroG* + resveratrol synthase experiment in Arabidopsis thaliana and tobacco, two of the most commonly used model species in plant research, based on our previous research on resveratrol synthesis. The resveratrol synthase used was the Polygonum cuspidatum-derived resveratrol synthase PcRS, which we reported in patent document CN2025104384598. After combining the coding gene of this mutant AroG* (nucleotide sequence shown in SEQ ID NO:2) without negative feedback inhibition or a further artificially optimized coding gene (nucleotide sequence shown in SEQ ID NO:3) with the Polygonum cuspidatum-derived resveratrol synthase gene PcRS, we found that the AroG* + PcRS combination could lead to heterologous accumulation of resveratrol in Arabidopsis thaliana and tobacco. Compared with the expression of the PcRS gene alone, co-expression of AroG* and PcRS increased the yield of resveratrol in plants by 2.1 times. Furthermore, using a secondary cell wall-specific promoter to drive the expression of PcRS and AroG* in the model plant Arabidopsis thaliana improved the saccharification efficiency of its cell wall by 83%. Therefore, this technical solution not only establishes a new method for synergistically increasing the resveratrol synthesis efficiency through the synergistic effect of AroG* and PcRS genes, but also pioneers a new method that both produces the high-value medicinal component resveratrol and modifies the composition and structure of plant cell walls to improve biomass digestibility. Specifically, this invention provides the following technical solution.
[0008] The first aspect of the present invention provides a 3-deoxy-D-arabinohepanoate synthase, or a 3-deoxy-D-arabinohepanoate-7-phosphate synthase (DAHPS / AroG) mutant AroG*, which is a polypeptide or a conserved variant thereof with an amino acid sequence as shown in SEQ ID NO:1. The conserved variant polypeptide is a polypeptide with an amino acid sequence that has more than 90% homology to SEQ ID NO:1, preferably more than 92%, preferably more than 95%, preferably more than 96%, preferably more than 97%, preferably more than 98%, more preferably more than 99%, and has the function of a 3-deoxy-D-arabinohepanoate synthase mutant (AroG*) and is free from shikimic acid feedback inhibition.
[0009] A second aspect of the invention provides a gene encoding the above-mentioned 3-deoxy-D-arabino-heptanolate synthase mutant (AroG*).
[0010] Preferably, the gene encoding the mutant AroG* is a polynucleotide with a nucleotide sequence as shown in SEQ ID NO:2 or SEQ ID NO:3.
[0011] A third aspect of the invention provides a dual-enzyme gene composition for increasing resveratrol yield and / or improving plant cell wall digestibility, comprising the gene of the 3-deoxy-D-arabino-heptanurate synthase mutant (AroG*) as described above (AroG*) and a resveratrol synthase gene. Preferably, the resveratrol synthase is selected from the following sources: Polygonum cuspidatum, Vitis vinifera, and Arachis hypogaea.
[0012] The cell wall digestibility refers to the saccharification efficiency of the cell wall, the sugar degradation efficiency of the cell wall, the degradability of the cell wall, and the bioconversion rate of lignocellulose biomass.
[0013] Preferably, the resveratrol synthase described above is a resveratrol synthase PcRS derived from Polygonum cuspidatum, the amino acid sequence of which is shown in SEQ ID NO:4, and the nucleotide sequence of the encoding gene PcRS is shown in SEQ ID NO:5.
[0014] In one embodiment, when the above-mentioned dual-enzyme gene composition is used to increase the yield of resveratrol in plants, a 35S promoter, such as the cauliflower mosaic virus (CAMV) 35S promoter, or a Ubi promoter, such as the ubiquitin gene promoter derived from maize, can be used to drive the expression of the AroG* gene and the PcRS gene.
[0015] In another implementation, when used to improve plant cell wall digestibility, the secondary cell wall synthesis gene PtCesA8 promoter (PtCesA8, phytozome sequence number: Potri.004G059600) and / or the gene PtDUF579 promoter (or pPtrDUF579-35smini, phytozome sequence number: Potri.005G141300) are used to drive the expression of the target genes AroG* and PcRS.
[0016] The nucleotide sequence of promoter pPtCesA8 is shown in SEQ ID NO:6; the nucleotide sequence of promoter pPtDUF579 (or pPtrDUF579-35smini) is shown in SEQ ID NO:7.
[0017] In the above-mentioned dual-enzyme gene composition, the AroG* gene and the PcRS gene are respectively in the form of expression cassette / expression frame or in the form of expression plasmid. That is, the dual-enzyme gene composition includes expression cassette / expression frame of genes AroG* and PcRS, or includes expression plasmid of genes AroG* and PcRS.
[0018] Optionally, when the above dual-enzyme gene composition includes expression plasmids for genes AroG* and PcRS, genes AroG* and PcRS are located on their respective expression plasmids, or genes AroG* and PcRS are cloned on the same plasmid to form a fusion gene.
[0019] Preferably, the plasmid vector for the above expression plasmid is selected from binary Agrobacterium vectors and vectors that can be used for plant micro-bombardment.
[0020] For example, the plasmid vector may be selected from the following group: pHB-YFP, pHB-FLAG, pBin19, pUN1301, fluorescent reporter vector pGreenII0800-LUC, pCAMBIA3300, pCAMBIA1300, pCAMBIA1301, pCAMBIA2300, pCAMBIA2301, pBI121, pTF102, etc., which are vectors used for plant transgenic purposes or modified vectors.
[0021] A fourth aspect of the present invention provides the use of the above-described dual-enzyme gene composition in increasing plant resveratrol yield and / or improving plant cell wall digestibility, which is a method for increasing plant resveratrol yield and / or improving plant cell wall digestibility, comprising the following steps:
[0022] The AroG* and PcRS expression cassettes described above were used to transform plant cells or tissues using Ti plasmids, Ri plasmids, plant virus vectors, direct DNA transformation, microinjection, or electroporation. The transformed plant tissues were then cultured into plants to obtain transgenic plants overexpressing the AroG* and PcRS genes.
[0023] The AroG* expression cassette and PcRS expression cassette were cloned onto plant chromosomes using gene editing technology to obtain transgenic plants overexpressing the AroG* and PcRS genes; and / or
[0024] The expression plasmids of AroG* and PcRS described above were transformed into plant cells or tissues using Agrobacterium-mediated transformation, and the transformed plant tissues were cultured into plants to obtain transgenic plants that overexpress the genes AroG* and PcRS.
[0025] The aforementioned Agrobacterium can be selected from Agrobacterium tumefaciens, Agrobacterium LBA4404, Agrobacterium EHA105, and Agrobacterium GV3101. For example, the recombinant plasmid can be transferred into an Agrobacterium strain using a freeze-thaw method to form a microbial engineered bacterium, which can then be used to transfect plants to obtain transgenic plants.
[0026] The gene editing technologies mentioned above can be selected from the following group: homologous double crossover, TALEN system, CRISPR-Cas9 system, CRISPR-Cpf1 system, CRISPR-Cas12 system, CRISPR-Cas12a system, CRISPR-BEST system, and MuGENT.
[0027] This invention newly discovers an artificially optimized 3-deoxy-D-arabino-heptanuronate synthase (DAHPS / AroG*) that stimulates resveratrol synthase, thereby integrating plant metabolic engineering and cell wall engineering for synergistic operation. The AroG* mutant enzyme can continuously and efficiently provide a supply of precursors, solving the problem of insufficient phenylpropane precursors in resveratrol synthesis. Compared with the expression of the PcRS gene alone, co-expression of the AroG* and PcRS genes increased the resveratrol yield in plants by 2.1 times; using a secondary cell wall-specific promoter to drive the expression of PcRS and AroG* in the model plant Arabidopsis thaliana improved its cell wall saccharification efficiency by 83%. Therefore, the technical solution of this invention has the potential to enable large-scale production of resveratrol: utilizing this optimized metabolic pathway can increase the yield of resveratrol produced by the plant chassis and reduce production costs. In addition, it can promote biofuel production and waste resource recycling: improving the efficiency of plant cell wall sugar degradation makes plants easier to convert into biofuels or biomaterials, reducing pretreatment costs and waste accumulation, promoting the circular economy and driving sustainable energy development. Attached Figure Description
[0028] Figure 1 The qualitative analysis of resveratrol biosynthesis in tobacco is shown. The gene PcRS / AroG* is transiently expressed in tobacco leaves; from left to right, the images show UV spectrum, primary mass spectrum, and liquid chromatography. Blue indicates the detection results of polygalactoside, and red indicates the detection results of resveratrol.
[0029] Figure 2The constitutive expression vector construction and transgenic line identification are shown. (a) Schematic diagrams of the three expression vector constructions; (b) PCR electrophoresis results of genomic DNA from transgenic plants, with WT as the negative control group; each vector had three independent lines; (c) Analysis of gene expression levels of PcRS / AroG* in wild-type and transgenic plants, with values representing the mean ± standard error of three replicates. One-way ANOVA was used for significance analysis (***p<0.001, ****p<0.0001); (d) Western blot validation of P / AP lines transgenic plants. In the figures, P represents PcRS, A represents AroG*, and AP represents PcRS+AroG*.
[0030] Figure 3 The results of the analysis of lignin content in the cell walls of transgenic materials are shown. The total lignin content was quantified using two methods: acetylation (AcBr) and thioacidolysis. The bars in the bar chart represent the biologically repeated mean values.
[0031] Figure 4 The quantitative analysis of seven oligosaccharides in hemicellulose of the cell wall of transgenic plants was shown.
[0032] Figure 5 The saccharification efficiency (sugar release from biomass) analysis curves of the transgenic materials are shown. (a) represents A lines, (b) represents P lines, and (c) represents ACP lines. Saccharification of biomass was performed on mature, senescent stems of wild-type and transgenic plants after starch removal pretreatment. The figure shows the sugar release from biomass after enzymatic hydrolysis at four time points: 8, 24, 48, and 72 hours. Detailed Implementation
[0033] This invention establishes a novel method for producing resveratrol compounds using plants as a substrate; it also discovers a new strategy that enables resveratrol to be incorporated into the cell wall, thereby improving cell wall digestion efficiency. In the process of protecting endangered wild resources of resveratrol bioactive products, we combined an artificially optimized shikimic acid-free 3-deoxy-D-arabino-heptanurate synthase (AroG*) with the resveratrol synthase PcRS derived from Polygonum cuspidatum. This combination enabled heterologous synthesis of resveratrol compounds in model plants (tobacco and Arabidopsis thaliana), increasing resveratrol yield. The resveratrol yield in these plants was 2.1 times that of plants expressing only the PcRS gene, achieving the goal of highly efficient heterologous resveratrol synthesis. On the other hand, lignin biomass has become a new type of renewable energy that can replace petroleum due to its abundant carbon storage. Its depolymerization products can be used in industries such as energy fuels, agriculture and chemical products. However, its poor degradation properties hinder the further utilization of lignin. Our strategy of heterologously expressing AroG* and PcRS genes in plants can reshape the cell wall structure, which increases the saccharification efficiency of lignocellulose by 83% compared with the wild-type control. This creates a new type of biomass that can accumulate the medicinal active substance resveratrol and improve the degradation properties of lignocellulose.
[0034] In the experiment, the resveratrol synthase PcRS gene in the Polygonum cuspidatum genome was transiently expressed in Nicotiana benthamiana under the drive of the 35S promoter, and could synthesize resveratrol-like substances in tobacco leaves, with a total product accumulation of 1684.8 ± 138.4 pmol·mg⁻¹. 1 FW; while no resveratrol was detected in the control group (empty vector and AroG* single gene expression group). When AroG* and PcRS were co-expressed, the total accumulation of resveratrol increased to 2352.0±189.7 pmol·mg. -1 The yield of resveratrol was increased by 40% compared with the expression of PcRS single gene, which verified that AroG* and PcRS can synergistically promote the synthesis of resveratrol.
[0035] The resveratrol synthase PcRS, driven by the secondary cell wall-specific promoters PtrCesA8 or PtrDUF579-35smini, was heterologously expressed in Arabidopsis thaliana, accumulating up to 114.31 ± 28.31 ng·mg in stem tissue. -1 When FW's resveratrol compounds were co-expressed with AroG* and PcRS in Arabidopsis stem tissue, the total resveratrol compound content increased to 2.1 times that of plants expressing the PcRS single gene, indicating the establishment of a new plant synthesis strategy for resveratrol bioactive substances.
[0036] The composition and structure of the cell wall in Arabidopsis thaliana exogenously overexpressing AroG* and PcRS were altered. Compared with the wild-type control, the lignin content, which provides rigid support for the cell wall, decreased by 17%, G-type lignin monomers decreased by 12%, and the S / G ratio increased by 16%. Crystalline cellulose in the cell wall decreased by 12%, while all seven oligosaccharides of hemicellulose changed to varying degrees, with glucose and xylose showing the most significant changes, increasing by 59% and 29%, respectively. This may have made the cell wall structure looser due to the reduction in lignin and crystalline cellulose, increasing the accessibility of cell wall polysaccharides.
[0037] The saccharification efficiency of lignocellulose biomass from PcRS transgenic Arabidopsis was 55% higher than that of wild-type control, while the saccharification efficiency of lignocellulose from Arabidopsis co-transgenic with AroG* and PcRS was 83% higher. This indicates that a new strategy for improving cell wall sugar degradation efficiency based on resveratrol metabolic engineering has been established, and this strategy has no significant negative impact on plant biomass accumulation.
[0038] The above experimental results suggest that applying the combination of AroG* and PcRS genes to regulate non-traditional lignin biosynthesis and create modified lignin, while also applying it to the production platform of resveratrol-like natural active products, can further broaden the application scope and high-value utilization scenarios of lignin.
[0039] As used in this article, the terms “transgenic plant,” “genetically engineered plant,” and “(plant) mutant” have the same meaning, referring to plants that have been genetically engineered from wild-type plants, especially plants modified with the AroG* and PcRS genes that have improved resveratrol production and / or cell wall sugar degradation efficiency.
[0040] In the description of the technical solutions of this invention, the term "and / or" used in terms such as "A and / or B" or "A and / or B" is intended to include both A and B; A or B; A (alone); and B (alone). Similarly, the term "and / or" used in phrases such as "A, B, and / or C" is intended to cover each of the following embodiments: A, B, and C; A, B, or C; A or C; A or B; B or C; A and C; A and B; B and C; A (alone); B (alone); C (alone).
[0041] As used herein, the terms “(resveratrol yield / cell wall digestibility) increase,” “enhancement,” or “increase” can mean an increase of at least 10% compared to a reference level (e.g., wild-type plants), such as an increase of at least about 20%, or at least about 30%, or at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least about 90%, or up to and including 100%, or any increase between 10% and 100%; or an increase of at least about 2 times, or at least about 3 times, or at least about 4 times, or at least about 5 times, or at least about 10 times compared to a reference level.
[0042] In this document, for the sake of simplicity, the name of a protein, such as PcRS, and its encoding gene (DNA), are sometimes used interchangeably. Those skilled in the art should understand that they represent different types of substances in different descriptive contexts. Their meanings are readily understood by those skilled in the art based on the context. For example, when describing the function or category of resveratrol synthase derived from Polygonum cuspidatum, PcRS refers to a protein; when used as a gene description, it refers to the gene encoding that protein.
[0043] As used herein, "exogenous" or "heterogeneous" refers to the relationship between two or more nucleic acid or protein sequences from different sources, or the relationship between a protein (or nucleic acid) from different sources and a host cell. For example, if the combination of nucleic acid and host cell is not normally naturally occurring, then the nucleic acid is exogenous to that host cell. A particular sequence is "exogenous" to the cell or organism in which it is inserted.
[0044] The artificially optimized amino acid sequence SEQ ID NO:1 of 3-deoxy-D-arabino-heptanurate synthase (AroG*) is a heterologous protein expressed in plants, and its synergistic promoting effect on PcRS is unexpected.
[0045] Those skilled in the art will expect that it is reasonable for a polypeptide with high homology (identity) to the amino acid sequence SEQ ID NO:1, for example, more than 90% of which is a conserved variant, to have the same or similar function.
[0046] As used herein, the term "conservative variant polypeptide" refers to a polypeptide that substantially retains the same biological function or activity as the polypeptide. The variant specifically refers to a small number of amino acid mutations, and the "mutation" includes, but is not limited to, the substitution, deletion, insertion, or chemical modification of amino acid residues, preferably a positive mutation, i.e., a mutation that enhances AroG* function and eliminates shikimic acid feedback inhibition. The substitution can be a non-conservative substitution, a conservative substitution, or a combination of non-conservative and conservative substitutions. "Conservative" amino acid substitution or mutation refers to the interchangeability of residues with similar side chains, and therefore generally includes the substitution of amino acids in the polypeptide with amino acids from the same or similar amino acid definition class. However, as used herein, if a conserved mutation can alternatively be an aliphatic to aliphatic, nonpolar to nonpolar, polar to polar, acidic to acidic, basic to basic, aromatic to aromatic, or restriction residue to restriction residue substitution, then a conserved mutation does not include hydrophilic to hydrophilic, hydrophobic to hydrophobic, hydroxyl-containing to hydroxyl-containing, or small residue to small residue substitution. As is known in this technical field, common examples of conservative substitutions include: substitutions between aromatic amino acids F, W, and Y; substitutions between hydrophobic amino acids L, I, and V; substitutions between polar amino acids Q and N; substitutions between basic amino acids K, R, and H; substitutions between acidic amino acids D and E; and substitutions between hydroxyl amino acids S and T. Furthermore, A, V, L, or I can be conservatively mutated into another aliphatic residue or another nonpolar residue.
[0047] The construction of transgenic plants overexpressing the two genes AroG* and PcRS can be achieved using traditional Agrobacterium-mediated transformation with recombinant plasmids or gene editing technology.
[0048] For example, a binary Agrobacterium vector, such as pCAMBIA2300, can be used as a backbone to clone expression cassettes of genes AroG* and PcRS onto a vector plasmid, yielding a nucleic acid construct. The expression cassette contains biological elements such as a promoter, gene fragments AroG* and PcRS, and a terminator.
[0049] In specific embodiments, the gene AroG* and PcRS sequence fragments (e.g., SEQ ID NO:3 and SEQ ID NO:5) can typically be obtained using PCR amplification, recombination, or artificial synthesis. For PCR amplification, conventional techniques can be used to amplify the AroG* and PcRS genes from the genomic DNA, and primers can be designed based on the nucleotide sequences disclosed in this invention, especially the open reading frame sequences.
[0050] As used herein, the terms "expression cassette," "expression box," "gene expression cassette," or "nucleic acid construct" refer to a gene expression system containing all the necessary elements required for expressing the target proteins AroG* and PcRS. Typically, it includes the following elements: a 35S promoter or Ubi promoter, a pPtCesA8 or pPtrDUF579-35smini promoter, the gene sequence encoding the protein, a tag protein, and a terminator; additionally, it may optionally include signal peptide coding sequences such as mCherry (red fluorescent protein), GFP (green fluorescent protein), or YFP (yellow fluorescent protein); these elements are operatively linked.
[0051] As used herein, the term "expression construct" or "expression building block" refers to a recombinant DNA molecule that may contain one or more gene expression cassettes. These "constructs" are typically contained within an expression vector (plasmid vector).
[0052] As used herein, “operationally linked” or “operationally connected” refers to a functional spatial arrangement of two or more nucleic acid regions or sequences. For example, the Ubi promoter region is positioned at a specific location relative to the target gene AroG* nucleic acid sequence SEQ ID NO:1, such that transcription of the nucleic acid sequence is guided by the promoter region, thereby the promoter region is “operationally linked” to the nucleic acid sequence.
[0053] The nucleic acid constructs described in this invention can be manipulated in various ways to ensure the expression of the genes AroG* and PcRS. The nucleic acid constructs can be manipulated according to the different expression vectors or requirements before insertion into the vector. Techniques for altering polynucleotide sequences using recombinant DNA methods are known in the art.
[0054] In some embodiments, the nucleic acid construct is a vector. The vector can be a cloning vector, an expression vector, or a gene knock-in vector. The nucleic acid sequences SEQ ID NO:3 and SEQ ID NO:5 of the present invention can be cloned into many types of vectors, such as plasmids, phage particles, phage derivatives, animal viruses, and granules. Cloning vectors can be used to provide the coding sequence of the protein or polypeptide of the present invention. Expression vectors can be provided to cells in the form of bacterial or viral vectors. Specific expression of the AroG* and PcRS genes of the present invention is typically achieved by operably linking the nucleic acid sequences SEQ ID NO:3 and SEQ ID NO:5 to the 35S promoter and incorporating the construct into an expression vector. This vector is suitable for replication and integration into eukaryotic cells. Typical expression vectors contain expression control sequences that can be used to regulate the expression of the desired nucleic acid sequence.
[0055] Gene knock-in vectors can be used to integrate AroG* and PcRS, as described herein, into regions of interest in the host genome. Typically, in addition to the polynucleotide sequences described herein, gene knock-in vectors may also contain 5' and 3' homologous arms required for genomic homologous recombination. In some embodiments, the nucleic acid constructs described herein contain 5' homologous arms, the polynucleotide sequences described herein, and 3' homologous arms.
[0056] Methods well known to those skilled in the art can be used to construct nucleic acid constructs. These methods include in vitro recombinant DNA techniques, DNA synthesis techniques, and in vivo recombination techniques. The DNA sequence can be efficiently ligated to an appropriate promoter in the expression vector to direct mRNA synthesis. Representative examples of these promoters include: the lac or trp promoter of *E. coli*; the PL promoter of *λ* phage; eukaryotic promoters including the CMV immediate early promoter, the HSV thymidine kinase promoter, early and late SV40 promoters, LTRs of retroviruses, and other known promoters that control gene expression in prokaryotic or eukaryotic cells or their viruses. The expression vector also includes a ribosome binding site for translation initiation and a transcription terminator. Furthermore, the expression vector preferably contains one or more selective marker genes to provide phenotypic traits for selecting host cells for transformation, such as dihydrofolate reductase, neomycin resistance, and green fluorescent protein (GFP) for eukaryotic cell culture, or tetracycline, ampicillin resistance, or chloramphenicol for *E. coli*, *Agrobacterium*, etc.
[0057] When the polynucleotides AroG* and PcRS of this invention are expressed in plant cells, transcription is enhanced when an enhancer sequence is inserted into the vector. Enhancers are cis-acting factors of DNA, typically approximately 10 to 300 base pairs, that act on the promoter to enhance gene transcription. Examples include the SV40 enhancer (100 to 270 base pairs) located late on the replication origin side, the polytumor enhancer located late on the replication origin side, and adenovirus enhancers.
[0058] Vectors containing appropriate DNA sequences and appropriate promoters or control sequences can be used to transform appropriate host cells so that they can express proteins.
[0059] When constructing transgenic plants using the traditional Agrobacterium-mediated transformation method, the methods for constructing transgenic plants include:
[0060] 1) Provide Agrobacterium carrying an expression vector, wherein the expression vector contains sequences such as AroG* and PcRS genes and promoter 35S;
[0061] 2) Contact plant cells, tissues, or organs with Agrobacterium in step 1) to transfer the coding sequence into the plant cells and integrate it into the chromosomes of the plant cells;
[0062] 3) Select plant cells or tissues into which the coding sequence has been transferred;
[0063] 4) Regenerate plants from the plant cells or tissues in step 3).
[0064] The method described herein can be used to construct transgenic plants with different uses.
[0065] In summary, the positive and progressive effects of this invention are mainly as follows:
[0066] 1. A novel strategy for the efficient synthesis of resveratrol derivatives is proposed:
[0067] Currently, wild resources of natural sources of resveratrol are becoming increasingly depleted (such as medicinal Polygonum cuspidatum). This invention not only successfully achieved heterologous synthesis of resveratrol in model plants (tobacco and Arabidopsis thaliana), but also demonstrated that the resveratrol yield in plants co-expressing the artificially designed and optimized AroG* and PcRS genes was 2.1 times that of plants expressing only the PcRS gene, achieving the goal of efficient heterologous synthesis of resveratrol and proposing a new strategy for the synthesis of natural resveratrol.
[0068] 2. To create a new type of high-value and easily degradable lignocellulosic biomass material:
[0069] Lignin biomass, due to its abundant carbon reserves, has become a novel renewable energy source that can replace petroleum. Its depolymerization products can be used in industries such as energy fuels, agriculture, and chemical products. However, its recalcitrant degradation properties hinder the further utilization of lignin. The strategy of heterologously expressing the AroG* and PcRS genes in plants provided by this invention can remodel the cell wall structure, thereby increasing the saccharification efficiency of lignocellulose by 83% compared with the wild-type control. This creates a novel biomass that can accumulate the medicinal active substance resveratrol and improve the degradation properties of lignocellulose.
[0070] The present invention will be further described in detail below with reference to specific embodiments. It should be understood that the following embodiments are for illustrative purposes only and are not intended to limit the scope of the invention.
[0071] Example
[0072] The examples involve the addition amount, content and concentration of various substances, and unless otherwise specified, the percentage content refers to the mass percentage content.
[0073] In the embodiments described herein, unless otherwise specified, the temperature generally refers to room temperature (15-30°C).
[0074] The molecular biology experiments in this embodiment, including plasmid construction, enzyme digestion, competent cell preparation, and transformation, were mainly conducted in accordance with *Molecular Cloning: A Laboratory Manual* (3rd Edition), edited by J. Sambrook and DW. Russell (USA), translated by Huang Peitang et al., Science Press, Beijing, 2002. For example, the methods for competent cell transformation and competent cell preparation were both performed according to Chapter 1, page 96 of *Molecular Cloning: A Laboratory Manual* (3rd Edition). Specific experimental conditions could be determined through simple experiments if necessary.
[0075] PCR amplification experiments should be performed according to the reaction conditions provided by the plasmid or DNA template supplier or the kit instructions. Adjustments can be made through simple experiments if necessary.
[0076] The primer synthesis and gene sequencing in the examples were commissioned to Sangon Biotech (Shanghai) Co., Ltd. and Genscript Biotech Co., Ltd.
[0077] The molecular biology methods and transgenic plant construction methods, including the construction of AroG* and PcRS overexpression plasmids, Agrobacterium-mediated transfection, and plant cultivation, are carried out using techniques commonly used in this field.
[0078] Data Analysis and Processing
[0079] All experimental data were analyzed using one-way ANOVA with Graphpad Prism 9.5, and the Dunnett-t test was used to analyze the significance of differences at the 0.05 significance level.
[0080] Some of the PCR primers used in the examples are listed in Table 1.
[0081] Table 1. Some PCR primers used in the examples
[0082]
[0083]
[0084] In Table 1, "-F" in the name represents positive; "-R" represents negative.
[0085] The RT-PCR primers used in the examples are listed in Table 2.
[0086] Table 2. RT-PCR-related primers used in the examples
[0087]
[0088] Experimental methods
[0089] 1. Cultivation of plant materials
[0090] Arabidopsis thaliana: After surface sterilization (70% ethanol, 30 s; rinse 4 times with sterile water) and deep sterilization (5% sodium hypochlorite, 10 min; rinse 3 times with sterile water), seeds were sown on 1 / 2 MS solid medium. When sterile culture was not required, Arabidopsis thaliana and tobacco seeds were directly sown on 1 / 2 MS solid medium (MS powder 2.16 g·L⁻¹). -1 20g / L of sucrose -1 7.4 g / L agar powder -1 On a plate (pH 5.7), the seedlings were placed in a 4°C refrigerator for 3 days and then cultured in an artificial climate chamber for one week. After that, the seedlings were transplanted into a potting mix (vermiculite, black soil, and perlite in a 3:1:0.5 ratio). An appropriate amount of green manure was added during the preparation of the potting mix.
[0091] Tobacco: Sow the seeds evenly on the soil, cover with plastic wrap to keep them moist and grow for 5 days, then remove the wrap and transplant individual plants one week later.
[0092] Arabidopsis thaliana artificial climate chamber (temperature 22℃, photoperiod 16 / 8h, humidity 50±5%).
[0093] 2. Construction of expression vector
[0094] First, primers were designed based on the genome sequence information of Populus trichocarpa, and the PtrCesA8 promoter sequence was amplified by PCR using the xylem genomic DNA of Nanjing Forestry University 895 as a template. The PcRS gene from Polygonum cuspidatum and the AroG* gene from Escherichia coli were synthesized and codon optimized by Genscript Biotech Co., Ltd.
[0095] Construction of tobacco transient transduction vector: The CDS sequence (excluding the stop codon) of the fully synthesized PcRS / AroG* gene was cloned into the multiple cloning site between AgeI and XhoI in the pEAQ-HT vector;
[0096] Steps for constructing stable genetic expression vectors in plants: 1) Construction of empty promoter vector: The vector pCAMBIA2300-35S-YFP-3Flag is digested with restriction enzymes EcoRI and KpnI to remove the 35S promoter. Then, the PtrCesA8 promoter / PtrDUF579-35smini promoter sequence is inserted between the EcoRI and KpnI sites to construct the empty promoter vector pCAMBIA2300-pPtrCesA8-YFP-3Flag / pCAMBIA2300-pPtrDUF579-35smini-YFP-3Flag; 2) Construction of overexpression vector: The YFP and Flag sequences are removed with restriction enzymes BamHI and BstEII. The AroG* sequence is inserted between the BamHI and BstEII restriction sites. The pCAMBIA2300-pPtrDUF579-35smin::AroG* vector was constructed. YFP was removed using the restriction enzymes KpnI and XbaI, and the PcRS sequence was inserted between the KpnI and XbaI restriction sites to construct the pCAMBIA2300-pPtrCesA8::PcRS* vector. 3) Polyclonal vector construction: The pCAMBIA2300-pPtrDUF579-35smin:AroG*-pPtrCesA8:PcRS* vector was constructed by cutting the pCAMBIA2300-pPtrDUF579-35smin:AroG*-pPtrCesA8:PcRS* vector using the restriction enzymes SacI and ApaI.
[0097] The primer sequences used to construct the vectors are shown in Appendix Table 1.
[0098] 3. Agrobacterium-mediated transformation
[0099] Take 1 μg of the plasmid to be transformed and add it to 50 μL of thawed Agrobacterium GV3101 competent cells. Then place the cells on ice, in liquid nitrogen, and in a 37°C water bath for 5 min each. Add antibiotic-free YEB liquid medium to a clean bench, and revive the cells at 220 rpm for 2 h in a shaker at 28°C. Centrifuge at 10,000 rpm for 5 min, discard the supernatant, and spread the remaining approximately 100 μL of bacterial culture evenly on multi-resistance (Kan+Rif+GM) solid YEB medium. Incubate at 28°C for 48–72 h.
[0100] 4. Transient expression in tobacco leaves
[0101] A single Agrobacterium strain was picked and placed in 5 mL of YEB medium (Kan+Rif) and incubated overnight at 28°C. The culture was then transferred at a 5% ratio to fresh resistant YEB medium and cultured with shaking for 16–24 h. The bacterial suspension was centrifuged at 4800 rpm for 10 min to precipitate the bacterial culture. The precipitate was diluted with injection solution (10 mM MgCl2 + 10 mM Mes-KOH + 20 μM acetylsylphenone) to an OD600 value of 0.6–0.8 and activated by standing at room temperature in the dark for 3 h. The solution was injected into the lower surface of tobacco leaves using a syringe, while simultaneously pressing the upper surface of the leaf with a fingertip to allow the infection to slowly spread throughout the leaf. After three days of incubation, a coin-sized leaf disc was collected for phenolic metabolite detection.
[0102] 5. Arabidopsis inflorescence infection transformation and transgenic material resistance screening
[0103] Transformation of Arabidopsis thaliana using the flower immersion method. Preparation before transformation: 1) Select wild-type Arabidopsis thaliana plants with stems approximately 10-15 cm tall after bolting and numerous flower buds for transformation. Remove the pods before transformation, and ensure the soil in the pots is fully moistened overnight. 2) Agrobacterium culture: Two days before transformation, inoculate a single colony into 5 mL of YEB medium (Kan+Rif) and incubate overnight at 28°C. Then, inoculate 1% of the colony into 200 mL of fresh resistant YEB medium. Continue culturing for 10-20 hours until OD600 ≈ 1.2-1.4. Collect the cells by centrifugation at 4800 rpm for 15 min, and dilute the cells with transformation buffer (5% Surcose + 0.02% SiLwet L-77) to an OD600 of approximately 0.8.
[0104] Transformation: Soak all Arabidopsis flower buds and buds in a beaker containing Agrobacterium solution for about 45 seconds. Wrap the rosette leaves and above of Arabidopsis with plastic wrap to maintain humidity. Place in the dark. After 24 hours, remove the film and place under normal light conditions to grow for 3-4 weeks. Harvest mature seeds of generation T0 and dry them in a seed cabinet at 28℃.
[0105] Resistance screening: T3 generation homozygous transgenic plants were obtained by culturing T0 generation seeds for multiple generations (see Method 2.2.1) and resistance screening (1 / 2 MS solid medium containing 50 μg·mL-1 Kan) for subsequent analysis.
[0106] 6. Identification of genetically modified plants
[0107] (1) Rapid extraction of plant DNA
[0108] Grinding: Take the plant material frozen in liquid nitrogen into a 2mL EP tube with steel balls; set the automatic grinder parameters to 60HZ, 60s, and quickly grind the material into powder;
[0109] DNA extraction precipitation: Add 500 μL of premixed solution (FP1:SDS = 9:1) to the ground sample, vortex until homogeneous, and place in an oven for 10 min; add 150 μL of FP2 and mix well, centrifuge at 12000 rpm for 10 min, and transfer the supernatant to a new 1.5 mL EP tube; add 500 μL of isopropanol to the supernatant, invert and mix well, and precipitate at -20℃ for half an hour.
[0110] DNA washing and dissolution: Wash twice with 70% ethanol, then dry the ethanol in a clean bench or oven. Dissolve in 70 μL ddH2O and store at -20°C.
[0111] (2) PCR identification
[0112] Using extracted plant DNA as a template, PCR amplification was performed with gene-specific primers. The amplification products were subjected to agarose gel electrophoresis, and a positive transgenic plant was identified by the detection of a product band of the correct size.
[0113] Table 2-1 PCR Amplification Procedure
[0114]
[0115]
[0116] (3) cDNA reverse transcription
[0117] RNA was extracted from plant material using the FastPure Universal Plant Total RNA Isolation Kit (Nanjing Novizan Biotechnology Co., Ltd., RC411-01), and then... One-Step gDNA Removal and cDNA Synthesis SuperMix (Beijing TransGen Biotech Co., Ltd., AT311) reverse transcribes gDNA into cDNA.
[0118] Table 2-2 Synthesis system with gDNA and first-strand cDNA removed
[0119]
[0120] Incubate at 42℃ for 15 min, heat at 85℃ for 5 s, and after the reaction is complete, place on ice or store at -20℃.
[0121] (4) Quantitative RT-PCR
[0122] Using TB Premix Ex Taq TMUsing (Takara, RR420A) reagents, with cDNA as a template, quantitative RT-PCR analysis was performed with gene-specific primers to analyze the relative expression levels of genes in transgenic plants.
[0123] Table 2-3 RT-PCR Amplification Procedure
[0124]
[0125] (5) Protein immunoblotting analysis
[0126] Soluble plant protein extraction and SDS-PAGE gel electrophoresis:
[0127] Plant stem tissue was flash-frozen in liquid nitrogen and ground into powder. 1 mL of 1X PBS (+100 mM PMSF, pH 7.5) was added, and the mixture was rotated and mixed at 4°C for 2 h. The mixture was then centrifuged at 12000 rpm for 10 min, and the supernatant was transferred to a new EP tube. After determining the protein concentration, 2X SDS loading buffer was added quantitatively, and the tube was boiled for 10 min. After centrifugation, 10–15 μL of the supernatant was collected and spotted onto wells of a 4–20% gradient SDS-PAGE gel for gel electrophoresis (100 V, 800 mA, 100 min).
[0128] Transfer membrane:
[0129] After SDS-PAGE electrophoresis, the gel and 0.2 μm PVDF membrane were cut to appropriate sizes. The PVDF membrane was first activated by soaking in methanol for 2 min, then rinsed with water for 1 min along with the gel, and then equilibrated with a balancing buffer for 3 min. The membrane was then rapidly transferred in a wet transfer apparatus for 14 min in the order of positive electrode-sponge-PVDF membrane-PAGE gel-negative electrode.
[0130] Antibody incubation:
[0131] After the transfer was completed, the membrane was placed in blocking buffer (1X TBST, 3% skim milk powder) and incubated overnight at 4°C with shaking. After blocking, the membrane was washed three times with TBST (1X TBST, 1% skim milk powder, the concentration of TBST used below) for 5 min each time. 10 mL of TBST containing 5 μL of primary antibody (1:2000 dilution) was added and incubated on a shaking incubator at room temperature for 2 h. After incubation, the membrane was washed three times with TBST for 10 min each time. Then, 1 μL of secondary antibody (1:5000 dilution) was added and incubated on a shaking incubator at room temperature for 1 h. The membrane was washed three times with TBST for 5 min each time. 200 μL of ECL ultrasensitive luminescent solution (Shanghai Tianneng Life Science Co., Ltd., 180-506) was added and evenly coated on the PVDF membrane, and imaging was performed using a chemiluminescence imaging analyzer (Tanon-5200).
[0132] 7. Methods for the determination of phenolic metabolites
[0133] Plant material was rapidly ground into powder in liquid nitrogen. 100 mg of the powder sample was taken and 1 mL of 80% methanol solution (containing 25 μM internal standard succinate) was added. The mixture was vortexed for 1 min and extracted overnight at 4 °C. The mixture was centrifuged twice at 12000 rpm for 10 min. The supernatant of the two centrifugal extracts was collected into a new 1.5 mL EP tube and evaporated to dryness using a cold trap. 500 μL of ethyl acetate was added and vortexed twice. The two supernatants were combined and evaporated to dryness again. 100 μL of methanol was added to redissolve the supernatant. After centrifugation, 80 μL of the supernatant was collected into a light-protected sample vial.
[0134] Detection was performed using high-performance liquid chromatography (HPLC), with a chromatographic column of [missing information]. C18 (2.1 mm × 100 mm, 2.1 μm), mobile phase was 0.1% formic acid water (A) and acetonitrile-0.1% formic acid (B); gradient elution program was as follows: flow rate 1 mL / min -1 0–5.00 min, 5% B; 5.00–21.00 min, 5%–50% B; 21.00–25.00 min, 50%–95% B; 25.10–35.0 min, 95%–5% B; 35.10–38.00 min, 5% B; column temperature 40℃.
[0135] Ultra-high performance liquid chromatography-mass spectrometry (UPLC-Q-TOF-MS) detection, chromatographic column: C18 (2.1 mm × 100 mm, 2.1 μm); mobile phase: 0.1% formic acid water (A) and acetonitrile-0.1% formic acid (B); gradient elution program as follows: flow rate 0.3 mL / min -1 The column temperatures were as follows: 0–2.00 min, 1% B; 2.00–7.00 min, 1%–15% B; 7.00–9.00 min, 15%–95% B; 9.00–9.10 min, 95%–1% B; 9.10–12.00 min, 1% B; column temperature 40℃. Mass spectrometry was performed using an electrospray ionization (ESI) source, negative ion detection, and scheduled multiple reaction monitoring (Scheduled MRM). The ionization voltage (IS) was 5.5 kV–4.5 kV, and the temperature was 550℃. The spray gas (GS1, N2) pressure was 50 psi, the auxiliary heating gas (GS2, N2) pressure was 60 psi, the curtain gas (CUR) pressure was 35 psi, and the collision gas (CAD) was set to Medium.
[0136] The metabolites were compared with resveratrol standards; UV-Vis spectroscopy, retention time, and mass spectrometry results showed they were the same substance. The amount of metabolites was quantified based on the resveratrol standards.
[0137] 8. Analysis of secondary cell wall components
[0138] (1) Preparation of AIR (alcohol-insoluble cell wall residue)
[0139] Take the Arabidopsis stem tissue to be tested, dry it in an oven at 40℃ for 3 days, and grind it into a fine powder. Weigh 50 mg of the sample into a 2 mL screw cap tube, add 1 mL of 70% ethanol, vortex to mix, sonicate for 20 min, centrifuge at 10000 rpm for 10 min and discard the supernatant. Add 1 mL of freshly prepared chloroform / methanol (1:1), suspend the precipitate by blowing or vortexing, vortex to mix, sonicate for 20 min, centrifuge at 10000 rpm for 10 min and discard the supernatant. Add 1 mL of acetone, suspend the precipitate by blowing or vortexing, vortex to mix, sonicate for 20 min, centrifuge at 10000 rpm for 10 min and discard the supernatant. Heat on a metal hot plate at 45℃ for 3-5 h until the acetone is completely evaporated. Add 1.5 mL of sodium acetate solution (0.1 M, pH 5.0) to each sample, resuspend the sample, heat on a hot plate at 80℃ for 20 min, and cool on ice. Add 10 μL of [unclear text - possibly a specific ingredient or solution] to the cooled sample. Amylase (SIGMA, E4862-50mL) and Pullulanase (SIGMA, E2412-50mL) were mixed by vortexing and incubated overnight at 37°C on a shaker. The reaction was terminated by heating at 100°C for 10 min, centrifuging at 10000 rpm for 10 min, and discarding the supernatant. 1 mL of H2O was added, and the mixture was washed three times with water. 1 mL of acetone was added, and the mixture was washed three times. After discarding the supernatant on the last wash, the mixture was heated at 45°C on a metal hot plate for 3-5 h until the acetone was completely evaporated.
[0140] (2) Determination of lignin content (acetyl bromide method, AcBr)
[0141] Weigh 1 mg of AIR into a 2 mL screw-cap tube, and simultaneously take an empty 2 mL white screw-cap tube as a control (subsequent operations are consistent with the sample tube); rinse the tube wall with 1 mL of acetone, collect all the powder at the bottom of the tube, and evaporate the acetone at 45℃; slowly add 100 μL of freshly prepared acetyl bromide solution (25%, acetyl bromide is soluble in glacial acetic acid) along the tube wall, react at 50℃ for 2 h, and continue reacting for another h, vortexing to mix once every 15 min during the reaction, and cool to room temperature on ice after the reaction is completed; add 400 μL of 2M sodium hydroxide solution and 70 μL of freshly prepared 0.5M hydroxylamine hydrochloride, and vortex to mix; accurately add glacial acetic acid to each tube to 2 mL, invert several times to mix, and centrifuge at 12000 rpm for 2 min; pipette 200 μL of the upper layer solution into a UV-specific 96-well plate, set the microplate reader to a wavelength of 280 nm to read the absorbance value, and perform three replicates for each sample. Calculate the % ABSL (acetyl bromide soluble lignin) content using the following formula;
[0142]
[0143] The coeff value varies among different species, with Arabidopsis having a coeff of 15.69; 0.539 cm represents the height of a 200 μL solution, i.e., the path length of ultraviolet light; weight is the weight of the measured AIR. Multiplying ABSL% by 10 gives the concentration value (μg / mg AIR).
[0144] (3) Determination of lignin monomer content (thioacidolysis)
[0145] Weigh 5 mg of AIR powder into a 2 mL screw-cap tube, add 1 mL of acetone to rinse the tube wall, collect the powder to the bottom of the tube, and evaporate the acetone to dryness at 45 °C on a hot stage; prepare the stock solutions for the standard curves of each lignin monomer, add them sequentially to the screw-cap tube according to several gradients (concentration / mass), mix well, evaporate to dryness at 45 °C on a hot stage, and follow the same procedures as for the sample tubes; under nitrogen blowing, add 1 mL of the reaction mixture (875 μL dioxane + 100 μL ethanethiol + 25 μL boron trifluoride), cap the tube (avoid air contact as much as possible), incubate at 95 °C for 4 h, mixing once every 1 h; cool on ice for 5 min; add 300 μL sodium bicarbonate (0.4 M), transfer the solution to a 10 mL glass tube; use 2 mL of... Rinse the 2 mL threaded tube with H2O and transfer the washing solution to a 10 mL glass tube; add 1 mL dichloromethane (containing 1 mg tetracosane / internal reference); vortex until the solution becomes an emulsion, let stand for 1 min, vortex again until the solution becomes an emulsion, centrifuge at 1500 rpm for 2 min to separate the organic and aqueous phases; use a glass Pasteur pipette to aspirate the lower organic phase (containing lignin decomposition products), then transfer it through a Pasteur tube containing 50 mg anhydrous sodium sulfate to a 2 mL threaded tube, and dry at 50 °C overnight; resuspend the sample in 500 μL dichloromethane, take 50 μL of the sample solution into a new threaded tube, and evaporate to dryness at 50 °C for 1-2 h; then add 50 μL pyridine and 50 μL... Derivatization was performed using N,O-bis(trimethylsilyl)acetamide; the reaction was carried out at room temperature for 5 h; 70 μL of the reaction product was transferred to a sample vial and loaded onto a gas-phase quadrupole time-of-flight mass spectrometer (GC-MS / MS7200QTOF). Mass spectrometry analysis was performed using an Agilent Tech. A blanking test with dichloromethane was performed before sample analysis; the content of the corresponding lignin monomers in the sample was calculated using a standard curve.
[0146] (4) Hemicellulose composition analysis (ion chromatography)
[0147] Accurately weigh 2 mg of dried AIR sample, add 10 μL of ribose solution (stock solution 5 mg / mL) as an internal control, rinse the tube wall with 500 μL of acetone, collect all powder at the bottom of the tube, and evaporate the acetone to dryness on a 45℃ hot metal stage; add 250 μL of 2M trifluoroacetic acid (TFA, stock solution concentration 13M) to each tube, tighten the cap, react at 121℃ for 90 min, cool on ice after the reaction, and centrifuge at 10,000 rpm for 10 min; transfer about 200 μL of supernatant to a 2 mL EP tube, being careful not to aspirate the precipitate at the bottom when transferring the supernatant (the precipitate is used for quantitative analysis of crystalline cellulose); prepare the stock solutions for the standard curves of each monosaccharide component, and add each component sequentially to the screw-cap tube according to the concentration gradient, and mix well; evaporate the TFA and standard curve solutions to dryness overnight on a 45℃ hot metal stage, and the subsequent operations are the same; dissolve the sample and standard in 1 mL of H2O, vortex centrifuge, and take 800 μL of the supernatant in a plastic sample bottle for loading;
[0148] (5) Analysis of crystalline cellulose content (Updegraff method)
[0149] The TFA-treated precipitate was used for quantitative analysis of crystalline cellulose. 1 mL of Updegraff reagent (acetic acid:nitric acid:water = 8:1:2) was added to the precipitate, vortexed, and reacted on a hot metal stage at 100°C for 30 min. After cooling on ice, the mixture was centrifuged at 10,000 rpm for 10 min, and the supernatant was discarded (approximately 250 μL of liquid was retained to prevent disturbing the precipitate). 1 mL of water was added, mixed, and centrifuged again, discarding the supernatant. 1 mL of acetone was added, and the mixture was washed 3–4 times. The acetone was evaporated to dryness on a hot metal stage at 45°C. 175 μL of 72% sulfuric acid was added to each tube, and the mixture was reacted at room temperature for 1 h. Then, 825 μL of water was added, mixed, and centrifuged at 10,000 rpm for 5 min. 8 μL of the supernatant was transferred to a new 2 mL EP tube, and water was added to bring the volume to 100 μL for further analysis.
[0150] The glucose content in the sample supernatant was determined using the anthrone method. A glucose standard solution (stock solution, 1 mg / mL) was prepared. 0, 2, 4, 6, 8, 10, 12, and 16 μL of the glucose standard solution were taken and diluted with water to a final volume of 100 μL to plot the glucose standard curve. Subsequent steps were the same as for the sample.
[0151] Add 200 μL of freshly prepared anthrone reagent (anthrone dissolved in concentrated sulfuric acid, 2 mg / mL) to the sample and standard, react at 80℃ for 30 min, and cool to room temperature on ice after the reaction; centrifuge at 10000 rpm for 1 min, and aspirate 200 μL of the supernatant into a 96-well microplate, and measure the absorbance at a wavelength of 625 nm in the microplate reader; calculate the crystalline cellulose content in the sample according to the standard curve.
[0152] 9. Cell wall glycosylation efficiency analysis
[0153] Weigh 10 mg of AIR powder into a 2 mL tube, add 0.13 μL of ProClin300 (SIGMA, 48912-U), 0.1 μL of Cellulase, and enzyme blend (SIGMA, SAE0020), and bring the volume to 650 μL with 50 mM citrate buffer (pH 6.2). Incubate at 50 °C and 220 rpm for 8, 24, 48, and 72 h. Centrifuge at 10000 rpm for 5 min and collect 5 μL of the supernatant in a 96-well plate. Plot a glucose standard curve. Take 0, 1, 2, 3, 4, and 5 μL of glucose standard, bring the volume to 5 μL, and add each to a 96-well plate. Add 150 μL of GOPOD solution to each well and mix thoroughly. Incubate at 42 °C for 20 min. Read the absorbance at 510 nm using a microplate reader. Perform three replicates for each sample.
[0154] Example 1: Transient co-expression of PcRS and AroG* genes in tobacco to heterologously synthesize resveratrol-like substances
[0155] Using an artificially optimized, feedback-free 3-deoxy-D-arabino-heptanuronate synthase (AroG*) and the resveratrol synthase gene from Polygonum cuspidatum, tobacco expression vectors driven by the 35S promoter were constructed via enzyme digestion and ligation as follows: experimental groups pHEAQ-35S::PcRS (PcRS expression vector), pHEAQ-35S::AroG* (shikimic acid pathway rate-limiting enzyme mutant expression vector, which can increase downstream metabolites of the shikimic acid pathway), and control group pHEAQ-HT (empty vector). The leaves of Nicotiana benthamiana were inoculated using an Agrobacterium-mediated transient transformation system. After 72 h of inoculation, leaf disc tissue from the infected area was collected for metabolite analysis, and qualitative identification was performed using UPLC-Q-TOF-MS (e.g., ...). Figure 1 As shown in Table 3, data acquisition and quantitative analysis were performed using liquid chromatography-HPLC.
[0156] Qualitative identification of resveratrol: The experimental group showed a chromatographic peak with the same retention time as the standard at RT=8.65min, and its UV characteristic absorption (λmax=306nm) and first-order mass spectrometry molecular ion peak ([MH]-m / z=227.0684) were consistent with the standard; (2) Qualitative identification of polysaccharide: A chromatographic peak with the same retention time as the standard was detected at RT=7.25min, which is the glycosylation modification product—polysaccharide. Quantitative analysis of resveratrol compounds: No stilbene compounds were detected in either the empty vector or the AroG* single expression group. The total stilbene content in the PcRS single expression group reached (1684.8±138.4pmol·mg). -1Of which resveratrol accounted for 21.0% (353.4±45.6 pmol·mg). -1 The content of polygalactoside was 79.0% (1331.4±113.1 pmol·mg). -1 When AroG* was co-expressed with PcRS, the total product yield increased to (2352.0 ± 189.7 pmol·mg). -1 (+40% vs PcRS group), with resveratrol increasing by 98.2% (700.1 ± 145.9 pmol·mg). -1 The increase in polydipsia glycoside was 24.1% (1651.9 ± 118.5 pmol·mg). -1 ).
[0157] Table 3. Quantitative analysis of resveratrol biosynthesis in tobacco.
[0158]
[0159] Note: Values are the mean ± standard error of three independent biological replicates (n=4); quantitative analysis is based on the content of resveratrol metabolites in tobacco leaves (pmol·mg). -1 ) indicates; ND indicates not detected.
[0160] Example 2: Stable expression of PcRS and AroG* genes in Arabidopsis thaliana, resulting in heterologous accumulation of resveratrol compounds.
[0161] Three expression vectors were constructed based on the pCAMBIA2300 backbone: (1) pPtCesA8::PcRS-Flag (P lines), where the PcRS coding sequence is driven by the poplar secondary cell wall-specific promoter PtCesA8; (2) pPtDUF579::AroG*-NOS (A lines), where the AroG* mutant, freed from shikimic acid feedback inhibition, is regulated by the xylem-specific promoter PtDUF579; and (3) binary co-expression vectors (AP lines), where the AroG* / PcRS co-expression system was constructed using one-step cloning and recombination technology. The Colombian ecotype (Col-0) Arabidopsis thaliana was transformed using Agrobacterium tumefaciens (GV3101)-mediated inflorescence immersion method. T1 generation transformed lines were obtained through kanamycin resistance screening, and multiple independent homozygous transgenic lines were continuously self-crossed to the T3 generation for subsequent experiments. Using the wild-type as a control group, genomic DNA PCR verification, qRT-PCR analysis of RNA expression levels, and Western blot analysis to further determine protein expression levels confirmed successful overexpression of the transgene in Arabidopsis thaliana. Figure 2 As shown.
[0162] UPLC-Q-TOF-MS analysis revealed endogenous resveratrol and its glycosylated derivatives in the methanol-soluble phenolic extracts of the main stems of PcRS transgenic Arabidopsis thaliana (P lines and AP lines). Quantitative analysis showed that, compared with the wild type, the single-gene expression group P lines accumulated 4.43±3.21 ng·mg. -1 FW's resveratrol and 66.06±11.34 ng·mg -1 The resveratrol glycosylation byproduct (Polygonin); under AroG* co-expression, AP lines significantly accumulated more resveratrol compounds, including 36.99±6.54 ng·mg. -1 FW = resveratrol and 111.33±12.87 ng·mg -1 The total stilbene content in the polysaccharide group was 2.1 times higher than that in the single-gene expression group. Resveratrol-like substances were not detected in the control group (WT&Alines) (see Table 4).
[0163] Table 4. Quantitative analysis of resveratrol metabolites accumulated in transgenic Arabidopsis thaliana
[0164]
[0165] Note: Quantitative analysis is expressed as the content of resveratrol metabolites detected in the main stem of Arabidopsis thaliana (ng·mg-1); P represents PcRS, A represents AroG*, and AP represents PcRS+AroG*.
[0166] Example 3: Changes in cell wall components of PcRS and AroG* transgenic Arabidopsis thaliana
[0167] Dried stem tissue material from mature Arabidopsis thaliana was collected, dried, ground, and destarched to obtain cell wall residues. The cell walls were mainly composed of lignin and cellulosic polysaccharides (cellulose and hemicellulose). The total lignin content was determined using the acetyl bromide (AcBr) method based on the cell wall residues. The results showed (see...). Figure 3 The total lignin content of A lines showed no significant difference, while the total lignin content of P lines and AP lines decreased significantly (P lines -21.06%, AP lines -16.98%, vs. WT). GC-MS quantitative analysis of each lignin monomer content was performed using the thioacid hydrolysis method; H-type monomers were not detected due to their extremely low concentration. The results showed that ( Figure 3(Table 5) In A-line plants, the contents of both G-type and S-type monomers increased significantly, and the S / G ratio also increased significantly by 11.7%. In P-line plants, the contents of both G-type and S-type monomers decreased to varying degrees (G -16.7%, S -20.7% vs. WT), while the S / G ratio did not change significantly. In AP-line plants, the G-type monomer content decreased by 11.6% (vs. WT), while the S-type lignin monomer content showed no difference from the wild type, thus the S / G ratio increased by 15.6% (vs. WT).
[0168] Residual cell wall components were treated with TFA, and the precipitate was used for the determination of crystalline cellulose. The hemicellulose content of the supernatant was determined by ion chromatography. The results are shown in Table 5. Figure 4 The crystalline cellulose content of the transgenic plants all showed a decreasing trend to varying degrees, with the decrease decreasing in the order of AP lines, P lines, and A lines, but the decrease did not exceed 17% (vs. WT). Among all monosaccharide components, xylose and glucose showed the most significant changes. Xylose is the main component of hemicellulose, while glucose originates from non-crystalline cellulose and xylglucan in hemicellulose. In the transgenic plants, the glucose content changed most significantly in AP lines, increasing by 58.87% (vs. WT), followed by P lines (34.50%, vs. WT) and A lines (23.18%, vs. WT). Xylose content increased significantly by more than 28.80% in P lines and AP lines, while xylose content decreased by 8.96% in A lines.
[0169] Table 5. Cell wall component analysis of transgenic plants
[0170]
[0171] Note: The total lignin content in the destarched cell wall material (AIR) of Arabidopsis thaliana from the Col-0 control group and various carriers was determined using the acetyl bromide (AcRr) lignin analysis method. The lignin monomer composition was determined using the thioacidolysis method. The crystalline cellulose content was determined using the anthrone method. The hemicellulose content was determined using ion chromatography. Values represent the mean of three biological replicates per row. The standard error is written after the mean. P-values compared to the control group are written in parentheses. Statistically significant differences (p<0.05) are indicated in bold. Student's test was used.
[0172] Example 5: PcRS and AroG* transgenic Arabidopsis thaliana exhibits enhanced cell wall degradability
[0173] The saccharification efficiency of the cell wall residues of Arabidopsis thaliana materials was tested. A significant difference in saccharification efficiency was observed between the transgenic lines and the wild type starting 8 hours into the experiment. The difference was most significant after 72 hours of saccharification treatment. The ratio of glucose content to cellulose content released after 72 hours was taken as the saccharification efficiency.
[0174] Experimental results (see) Figure 5 The transgenic materials exhibited varying levels of saccharification efficiency, reflecting the degradation efficiency of the Arabidopsis cell wall. The saccharification efficiency of A lines was 16% higher than that of the wild type, while that of P lines was 55% higher. Notably, the PcRS / AroG* co-expression line AP lines showed the greatest increase in saccharification efficiency, exceeding that of the wild type by 83%. This indicates a significant improvement in the degradability of the transgenic Arabidopsis cell wall.
[0175] Although the above embodiments use tobacco / Arabidopsis thaliana as an example to illustrate the technical solution of the present invention, the technical solution of the present invention is also applicable to other plants based on the disclosure of the present invention. Therefore, without departing from the spirit of the present invention, those skilled in the art can make various modifications or alterations to the present invention, and equivalent forms of various variations or modifications should also fall within the scope of the present invention.
[0176] It should also be noted that the listing and discussion of previously disclosed documents in this specification should not be construed as an admission that such documents are prior art or common knowledge.
[0177] References
[0178] 1. Wang Xinping, Guo Qin, Li Tian, et al. Research progress on extraction and detection methods of resveratrol in plants [J]. Journal of Food Safety and Quality Testing, 2020, 11(21):7957-7965. doi:10.19812 / j.cnki.jfsq11-5956 / ts.2020.21.049.
[0179] 2. Wu, Shukuan. Study on biosynthesis of resveratrol from transgenic hairy roots of mulberry [D]. Shandong Agricultural University, 2021. doi:10.27277 / d.cnki.gsdnu.2021.000828.
[0180] 3.Liu Mengsu,Wang Chao,Ren Xuefeng,et al.Remodelling metabolism forhigh-level resveratrol production in Yarrowia lipolytica[J].BioresourTechnol,2022,365:128178.doi:org / 10.1016 / j.biortech.2022.128178
[0181] 4.Shang Yanzhe,Zhang Ping,Wei Wenpeng,et al.Metabolic engineering forthe high-yield production of polydatin in Yarrowia lipolytica[J].BioresourTechnol,2023,381:129129.doi:org / 10.1016 / i.biortech.2023.129129
[0182] 5.Yao L,Zhang H,Liu Y,Ji Q,Xie J,Zhang R,Huang L,Mei K,Wang J,GaoW.Engineering of triterpene metabolism and overexpression of the ligninbiosynthesis gene PAL promotes ginsenoside Rg3 accumulation in ginseng plantchassis.J Integr Plant Biol.2022Sep;64(9):1739-1754.doi:10.1111 / jipb.13315.Epub 2022Jul 21.PMID:35731022.
[0183] 6.Wang,Pingping et al.“Production of bioactive ginsenosides Rh2 andRg3 by metabolically engineered yeasts.”Metabolic engineering vol.29(2015):97-105.doi:10.1016 / j.ymben.2015.03.003
[0184] 7.Tzin,Vered et al.“Expression of a bacterial feedback-insensitive3-deoxy-D-arabino-heptulosonate 7-phosphate synthase of the shikimate pathwayin Arabidopsis elucidates potential metabolic bottlenecks between primary andsecondary metabolism.” The New phytologist vol.194.2(2012):430–439.doi:10.1111 / j.1469–8137.2012.04052.
[0185] 8.Xu Li,Clint Chapple,Understanding Lignification:Challenges BeyondMonolignol Biosynthesis,Plant Physiology,Volume 154,Issue 2,October 2010,Pages 449-452,2010; https: / / doi.org / 10.1104 / pp.110.162842
[0186] 9.De Meester B,Madariaga Calderon B,de Vries L,Pollier J,Goeminne G,Van Doorsselaere J,Chen M,Ralph J,Vanholme R,Boerjan W.Tailoring poplar lignin without yield penalty by combining a null and haploinsufficientCINNAMOYL-CoA REDUCTASE2 allele.Nat Commun.2020Oct 6:11(1):5020.doi:10.1038 / s41467-020-18822-w.
[0187] 10.Zhang Yang et al.Wood forming tissue-specific expression of PdSuSyand HCHL increases holocellulose content and improves saccharification inPopulus.Forestry Research32(2021),1681-1688.doi:10.1007 / s11676-020-01220-9.
[0188] 11.Wilkerson,C G et al.“Monolignol ferulate transferase introduceschemically labile linkages into the lignin backbone.”Science.vol.344,6179(2014):90-3.doi:10.1126 / science.1250161.
[0189] 12.DEL RíO J C et al.Lignin Monomers from beyond the CanonicalMonolignol Biosynthetic Pathway:Another Brick in the Wall.ACS SustainableChemistry&Engineering8(13)(2020):4997-5012.doi:10.1021 / acssuschemeng.0c01109.
Claims
1. A 3-deoxy-D-arabino-heptulosonate synthase, also known as 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (AroG or DAHPS) mutant (AroG*), which is a polypeptide or a conserved variant thereof with an amino acid sequence as shown in SEQ ID NO:1, wherein the conserved variant is a polypeptide with an amino acid sequence having more than 90% homology to SEQ ID NO:1 and having the function of a 3-deoxy-D-arabino-heptulosonate synthase mutant (AroG*) without shikimic acid feedback inhibition.
2. The gene encoding the 3-deoxy-D-arabino-heptanol synthase mutant (AroG*) as described in claim 1.
3. The gene as described in claim 2, characterized in that, The gene encoding the mutant (AroG*) is a polynucleotide with a nucleotide sequence as shown in SEQ ID NO:2 or SEQ ID NO:
3.
4. A dual-enzyme gene composition for increasing resveratrol yield and / or improving cell wall digestibility in plants, characterized in that, Includes the gene (AroG*) of the 3-deoxy-D-arabino-heptanol synthase mutant (AroG*) as described in claim 1 and the resveratrol synthase gene; preferably, the resveratrol synthase is a resveratrol synthase selected from the following sources: Polygonum cuspidatum, Vitis vinifera, and Arachishypogaea.
5. The dual-enzyme gene composition according to claim 4, characterized in that, The resveratrol synthase is PcRS, a resveratrol synthase derived from Polygonum cuspidatum. The amino acid sequence of the resveratrol synthase PcRS is shown in SEQ ID NO:4, and the nucleotide sequence of the encoding gene PcRS is shown in SEQ ID NO:
5.
6. The dual-enzyme gene composition according to claim 4, characterized in that, When used to increase plant resveratrol yield, the expression of the AroG* gene and PcRS gene is driven by the 35S promoter or the Ubi promoter. When used to improve plant cell wall digestibility, the secondary cell wall synthesis gene PtCesA8 promoter (pPtCesA8, phytozome sequence number: Potri.004G059600) and / or the gene PtDUF579 promoter (or pPtrDUF579-35smini, phytozome sequence number: Potri.005G141300) are used to drive the expression of the target genes AroG* and PcRS. The nucleotide sequence of promoter pPtCesA8 is shown in SEQ ID NO:6; the nucleotide sequence of promoter pPtDUF579 (or pPtrDUF579-35smini) is shown in SEQ ID NO:
7.
7. The dual-enzyme gene composition according to claim 6, characterized in that, The AroG* gene and the PcRS gene are respectively in the form of expression cassettes / expression frames or in the form of expression plasmids. That is, the dual-enzyme gene composition includes expression cassettes / expression frames of genes AroG* and PcRS, or includes expression plasmids of genes AroG* and PcRS.
8. The dual-enzyme gene composition according to claim 6, characterized in that, When the dual-enzyme gene composition includes expression plasmids for genes AroG* and PcRS, genes AroG* and PcRS are located on their respective expression plasmids, or genes AroG* and PcRS are cloned on the same plasmid.
9. The dual-enzyme gene composition according to claim 7, characterized in that, The expression plasmid vector is selected from binary Agrobacterium vectors and vectors used for plant micro-bombardment.
10. The use of the dual-enzyme gene composition as described in claim 7 in increasing plant resveratrol yield and / or improving plant cell wall digestibility, wherein the method for increasing plant resveratrol yield and / or improving plant cell wall digestibility comprises the following steps: The AroG* expression cassette and PcRS expression cassette as described in claim 7 are used to transform plant cells or tissues using Ti plasmid, Ri plasmid, plant virus vector, direct DNA transformation, microinjection, or electroporation, and the transformed plant tissues are cultured into plants to obtain transgenic plants overexpressing the AroG* and PcRS genes; or Transgenic plants overexpressing the AroG* and PcRS genes were obtained by cloning the AroG* and PcRS expression cassettes onto plant chromosomes using gene editing technology; and / or The expression plasmids of AroG* and PcRS as described in claim 8 are transformed into plant cells or tissues using Agrobacterium-mediated transformation, and the transformed plant tissues are cultured into plants to obtain transgenic plants that overexpress the genes AroG* and PcRS.
